SLG
CYAD

Stanley-Laman Group’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Stanley-Laman Group’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-39,750
Closed -$1.05M – 303
2018
Q3 		$1.05M Buy
39,750
+1,225
+3% +$32.5K 0.26% 121
2018
Q2 		$1.15M Buy
+38,525
New +$1.15M 0.26% 110